- Home
- SNOW vs ALNY Comparison
SNOW vs ALNY Comparison
Compare SNOW & ALNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNOW
- ALNY
- Stock Information
- Founded
- SNOW 2012
- ALNY 2002
- Country
- SNOW United States
- ALNY United States
- Employees
- SNOW N/A
- ALNY N/A
- Industry
- SNOW Computer Software: Prepackaged Software
- ALNY Biotechnology: Pharmaceutical Preparations
- Sector
- SNOW Technology
- ALNY Health Care
- Exchange
- SNOW Nasdaq
- ALNY Nasdaq
- Market Cap
- SNOW 73.2B
- ALNY 59.6B
- IPO Year
- SNOW 2020
- ALNY 2004
- Fundamental
- Price
- SNOW $222.06
- ALNY $452.17
- Analyst Decision
- SNOW Strong Buy
- ALNY Strong Buy
- Analyst Count
- SNOW 44
- ALNY 29
- Target Price
- SNOW $250.12
- ALNY $435.04
- AVG Volume (30 Days)
- SNOW 7.9M
- ALNY 1.1M
- Earning Date
- SNOW 08-27-2025
- ALNY 10-30-2025
- Dividend Yield
- SNOW N/A
- ALNY N/A
- EPS Growth
- SNOW N/A
- ALNY N/A
- EPS
- SNOW N/A
- ALNY N/A
- Revenue
- SNOW $4,115,907,000.00
- ALNY $2,461,963,000.00
- Revenue This Year
- SNOW $29.49
- ALNY $58.79
- Revenue Next Year
- SNOW $23.02
- ALNY $39.75
- P/E Ratio
- SNOW N/A
- ALNY N/A
- Revenue Growth
- SNOW 28.36
- ALNY 5.01
- 52 Week Low
- SNOW $108.71
- ALNY $205.87
- 52 Week High
- SNOW $249.99
- ALNY $484.21
- Technical
- Relative Strength Index (RSI)
- SNOW 54.26
- ALNY 54.93
- Support Level
- SNOW $214.30
- ALNY $454.51
- Resistance Level
- SNOW $228.54
- ALNY $467.28
- Average True Range (ATR)
- SNOW 6.10
- ALNY 12.99
- MACD
- SNOW -0.68
- ALNY -4.32
- Stochastic Oscillator
- SNOW 28.53
- ALNY 24.98
About SNOW Snowflake Inc.
Founded in 2012, Snowflake is a fully managed platform that consolidates data hosted on different public clouds for centralized analytics and governance. Snowflake's cloud-native architecture allows users to independently scale the compute and storage layers, providing customers with optimized performance at lower costs. The company's data lake and data warehouse products support a variety of use cases, including business analytics, data engineering, and artificial intelligence. Snowflake is widely used by Fortune 2000 companies in financial services, media, and retail sectors.
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.